The rate of CD4 decline as a determinant of progression to AIDS independent of the most recent CD4 count

Epidemiology and Infection

Volumn 121, Issue 2, 1998, Pages 369-376

  Cozzi Lepri, A ^a,b   Sabin, C A ^a   Phillips, A N ^a   Lee, C A ^a   Pezzotti, P ^b   Rezza, G ^b   Dorrucci, M ^b   Alliegro, M B ^b   Boros, S ^b   Sinicco, A ^c   Tarantini, G ^d   Angarano, G ^e   Lazzarin, A ^f   Aiuti, F ^g   Zaccarelli, M ^h   Salassa, B ⁱ   Castelli, F ^j   Viale, P ^k   Mazzarello, G ^l   Barbanera, M ^m   Colangeli, V ⁿ   Ortona, L ^o   Pristera R ^p   Ursitti, M A ^q   Tirelli, U ^r   more..

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d CAVE   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h 2nd Division of Infectious Diseases   (Italy)

ⁱ AMEDEO DI SAVOIA HOSPITAL   (Italy)

^j UNIVERSITY OF BRESCIA   (Italy)

^k Ospedale Civile di Piacenza   (Italy)

^l UNIVERSITY OF GENOA   (Italy)

^m Livorno Hospital   (Italy)

ⁿ UNIVERSITY OF BOLOGNA   (Italy)

^o CATHOLIC UNIVERSITY   (Italy)

^p CENTRAL HOSPITAL OF BOLZANO   (Italy)

^q S MARIA NUOVA HOSPITAL   (Italy)

^r CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; REGRESSION ANALYSIS; SEROCONVERSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 7844220992     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S095026889800140X     Document Type: Article

References (33)

1. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 1167-70.
2. Phillips AN, Eron JJ, Bartlett JA, et al. HIV-1 RNA levels and the development of clinical disease. AIDS 1996; 10: 859-65.
3. Hughes MD, Johnson VA, Hirsch MS, et al. Monitoring plasma HIV-I RNA levels in addition to CD4 lymphocyte count improves assessment of antiretroviral therapeutic response. Ann Int Med 1997; 126: 929-38.
4. Mellors JW, Muñoz A, Giorgi JV, et al. Plasma viral load and CD4 lymphocyte count as prognostic markers of HIV-1 infection. Ann Int Med 1997; 126: 946-54.
5. Saag MS. Use of HIV viral load in clinical practice: back to the future. Ann Int Med 1997; 126: 983-5.
6. Phillips AN, Sabin CA, Elford J, et al. Acquired immunodeficiency syndrome (AIDS) risk in recent and long-standing human immunodeficiency virus type 1 (HIV-1) infected patients with similar CD4 lymphocyte counts. Am J Epidemiol 1993; 138: 870-8.
7. Phillips AN, Pezzotti P, Cozzi Lepri A, et al. CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study. AIDS 1994; 8: 1299-305.
8. Shi M, Taylor JMG, Currier RJ, et al. Replacing time since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. J Acquir Immune Def Syndr 1996; 12: 309-16.
9. Taylor JMG, Cumberland WG, Sy JP. A stochastic model for the analysis of longitudinal AIDS data. J Am Stat Ass. 1994; 89: 727-36.
10. Shi M, Taylor MGM, Muñoz A. Models for residual time to AIDS. Lifetime Data Analysis 1996; 2: 31-49.
11. Hendriks JCM, Satten GA, Longini IM, et al. Use of immunological markers and continuous-time Markov model to estimate progression to HIV infection in homosexual men. AIDS 1996; 10: 649-56.
12. Jewell NP, Nielsen JP. A framework for consistent prediction rules based on markers. Biometrika 1993; 80: 153-64.
13. Saah AJ, Mun̈oz A, Kuo V, et al. Predictors of the risk of development of acquired immunudeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1. A report from the multicenter AIDS cohort study. Am J Epidemiol 1992; 135: 1147-55.
14. Chene G, Easterbrook PJ, Jaczczak E, et al. Long-term survival in patients with advanced immunodeficiency. AIDS 1997; 11: 209-16.
15. Yong FHL, Taylor JMG, Bryant JL, et al. Dependence of the hazard of AIDS on markers. AIDS 1997; 11: 217-28.
16. Mariotto AB, Mariotti S, Pezzotti P, et al. Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: A comparison with male homosexuals. Am J Epidemiol 1992; 135: 428-37.
17. Sabin CA, Phillips AN, Elford J, et al. The progression of HIV disease in a haemophilic cohort followed for 12 years. Br J Haematol 1993; 83: 330-3.
18. Center for Diseases Control. Revision of CDC surveillance case definition for AIDS. MMWR 1987; 36: 1-5s.
19. Ancelle-Park R. Expanded European AIDS case definition. Lancet 1993; 341: 441.
20. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. N Engl J Med 1990; 322: 941-9.
21. Cooper CA, Gatell JM, Kroon S, et al. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. N Engl J Med 1993; 329: 297-303.
22. Swanson CE, Tindall B, Cooper DA. Efficacy of zidvoudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. AIDS 1994; 8: 625-34.
23. Fischl MA, Richman DD, Causey DM, et al. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. JAMA 1989; 262: 2405-10.
24. Pezzotti P, Phillips AN, Dorrucci M, et al. HIV exposure category and age in the progression to AIDS in a longitudinal study of 1199 individuals with known date of seroconversion. BMJ 1996; 313: 583-6.
25. Muñoz A, Sabin CA, Phillips AN. The incubation period of AIDS. AIDS 1997; 11 (Sup A): S69-S76.
26. SAS Institute Inc, SAS users guide: statistics. Version 6.11, Cary, NC.
27. Chiasson MA, Berenson L, Li W, et al. Declining AIDS mortality in New York (NYC). 4th conference on Retroviruses and Opportunistic Infections. Washington, January 1997 [Abstract 376].
28. Hogg RS, O'Shaughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997; 349: 1294.
29. Egger M, Hirschel B, Brancioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ 1997; 315: 1194-9.
30. DeGruttola V, Lange N, Dafni U. Modelling the progression of HIV-infection. J Am Stat Assoc 1991; 86: 569-77.
31. Phillips A, Lee CA, Elford J, et al. Prediction of progression to AIDS by analysis of CD4 lymphocyte counts in a haemophilic cohort. AIDS 1989:3: 737-41.
32. MAP Workshop, Marker paths, Stat Med 1993; 12: 2099-126.
33. Galai N, Muñoz A, Chen K, et al. Tracking of markers and onset of disease among HIV-1 seroconverters. Stat Med 1993; 12: 2133-45.